Age-related macular degeneration and retinal pigment epithelium wound healing

被引:0
作者
Ilene K. Sugino
Hao Wang
Marco A. Zarbin
机构
[1] University of Medicine and Dentistry of New Jersey,Institute of Ophthalmology and Visual Science
[2] New Jersey Medical School,undefined
来源
Molecular Neurobiology | 2003年 / 28卷
关键词
Age-related macular degeneration; retinal pigment epithelium; Bruch’s membrane; wound healing; organ culture; cell migration;
D O I
暂无
中图分类号
学科分类号
摘要
Choroidal new vessel (CNV) excision may improve vision in patients with age-related macular degeneration (AMD) by eliminating the source of subretinal bleeding and scarring. Visual recovery after CNV excision is usually poor in AMD patients, probably because of removal of the associated retinal pigment epithelium (RPE), coupled with the inability of native RPE at the edge of the dissection bed to resurface the iatrogenic RPE defect. Experiments using in vitro and in vivo RPE wound-healing models have provided insight into the factors that regulate RPE wound healing in situ. Wound-healing studies using aged submacular human Bruch’s membrane in organ culture show that resurfacing of localized RPE defects is influenced by the depth of damage to Bruch’s membrane as well as factors that are intrinsic to the aged RPE at the wound edge. The Bruch’s membrane organ-culture paradigm provides a surface for RPE wound healing that closely resembles the surface on which RPE must grow after CNV excision in AMD patients. An understanding of the factors that influence RPE wound healing might lead to treatments that stimulate RPE resurfacing and improve visual outcome after CNV excision.
引用
收藏
页码:177 / 194
页数:17
相关论文
共 406 条
[1]  
Klein R.(1992)Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 933-943
[2]  
Klein B.E.(1984)Age-related macular degeneration and blindness due to neovascular maculopathy Arch. Ophthalmol. 102 1640-1642
[3]  
Linton K.L.(1995)The prevalence of age-related maculopathy in the Rotterdam Study Ophthalmology 102 205-210
[4]  
Ferris F.L.(1995)Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study Ophthalmology 102 1450-1460
[5]  
Fine S.L.(1997)The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 7-21
[6]  
Hyman L.(1993)Age-related macular degeneration and choroidal neovascularization Am. J. Ophthalmol. 115 786-791
[7]  
Vingerling J.R.(2001)Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trialstap report 2 Arch. Ophthalmol. 119 198-207
[8]  
Dielemans I.(2001)Exudative age-related macular degeneration: fluorescein angiographic subtype prevalence Investig. Ophthalmol. Vis. Sci. 42 S311-789
[9]  
Hofman A.(1999)Surgical removal of subfoveal choroidal neovascularization in age- related macular degeneration Ophthalmology 106 782-1396
[10]  
Grobbee D.E.(1994)Visual results after surgical removal of subfoveal choroidal neovascular membranes Ophthalmology 101 1384-489